Increased expression of the membrane-bound CD40 ligand on peripheral CD4+ T cells in the acute phase of AQP4-IgG-seropositive neuromyelitis optica spectrum disorders

J Neuroimmunol. 2018 Dec 15:325:64-68. doi: 10.1016/j.jneuroim.2018.10.013. Epub 2018 Nov 1.

Abstract

Currently, no data are available regarding the expression levels of CD40L on CD4+ T cells in patients with neuromyelitis optica spectrum disorders (NMOSD). The percentage of circulating CD40L+CD4+ T cells was measured by flow cytometry in 23 NMOSD patients and 10 healthy controls. The ratio of CD40L+CD4+ to CD4+ T cells in patients at acute phase (18.28 ± 15.56%) was significantly higher than that in healthy controls (7.23 ± 5.94%, P = .032) and was positively correlated with disease severity (r = 0.532, P = .041). Thus, our results suggest an important role of this molecule in acute attacks of NMOSD.

Keywords: Acute phase; CD154; CD4(+) T cells; CD40 ligand; Neuromyelitis optica spectrum disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adult
  • Aquaporin 4 / blood*
  • Biomarkers / blood
  • CD4-Positive T-Lymphocytes / metabolism*
  • CD40 Ligand / biosynthesis
  • CD40 Ligand / blood*
  • CD40 Ligand / genetics
  • Female
  • Gene Expression
  • Humans
  • Immunoglobulin G / blood*
  • Male
  • Middle Aged
  • Neuromyelitis Optica / blood*
  • Neuromyelitis Optica / diagnosis*

Substances

  • AQP4 protein, human
  • Aquaporin 4
  • Biomarkers
  • Immunoglobulin G
  • CD40 Ligand